X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7343) 7343
Book Review (561) 561
Newsletter (559) 559
Publication (163) 163
Conference Proceeding (85) 85
Newspaper Article (48) 48
Magazine Article (38) 38
Dissertation (18) 18
Book Chapter (14) 14
Paper (9) 9
Web Resource (8) 8
Trade Publication Article (5) 5
Book / eBook (1) 1
Presentation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
amlodipine (5165) 5165
index medicus (4416) 4416
humans (3694) 3694
male (2820) 2820
hypertension - drug therapy (2363) 2363
hypertension (2318) 2318
female (2315) 2315
middle aged (2039) 2039
amlodipine - therapeutic use (1844) 1844
aged (1602) 1602
antihypertensive agents - therapeutic use (1452) 1452
blood pressure - drug effects (1423) 1423
pharmacology & pharmacy (1357) 1357
adult (1198) 1198
calcium channel blockers - therapeutic use (1133) 1133
peripheral vascular disease (1127) 1127
treatment outcome (981) 981
amlodipine - administration & dosage (961) 961
drug therapy, combination (957) 957
amlodipine - pharmacology (931) 931
animals (921) 921
hypertension - physiopathology (889) 889
cardiac & cardiovascular systems (817) 817
blood-pressure (750) 750
amlodipine - adverse effects (720) 720
antihypertensive agents - administration & dosage (715) 715
calcium channel blockers - pharmacology (706) 706
blood pressure (693) 693
double-blind method (676) 676
valsartan (615) 615
drug therapy (606) 606
rats (557) 557
research (541) 541
hypertension - complications (525) 525
antihypertensive agents - adverse effects (511) 511
drug combinations (501) 501
calcium channel blockers - administration & dosage (477) 477
hydrochlorothiazide (467) 467
nifedipine (444) 444
medicine, general & internal (433) 433
calcium channel blockers - adverse effects (432) 432
risk factors (426) 426
abridged index medicus (425) 425
tetrazoles - therapeutic use (421) 421
amlodipine besylate (419) 419
antihypertensive agents - pharmacology (414) 414
dose-response relationship, drug (406) 406
dosage and administration (396) 396
time factors (395) 395
calcium channel blockers (387) 387
prevention (372) 372
drugs (370) 370
mortality (367) 367
prospective studies (366) 366
analysis (358) 358
therapy (355) 355
angiotensin-converting enzyme inhibitors - therapeutic use (347) 347
double-blind (344) 344
efficacy (323) 323
care and treatment (320) 320
aged, 80 and over (319) 319
disease (311) 311
trial (309) 309
risk (300) 300
heart rate - drug effects (299) 299
management (298) 298
pharmacokinetics (292) 292
calcium channel blocker (289) 289
combination therapy (289) 289
medicine & public health (284) 284
angiotensin ii type 1 receptor blockers - therapeutic use (278) 278
outcomes (278) 278
antihypertensive drugs (267) 267
chemistry, analytical (266) 266
pharmaceutical industry (262) 262
tetrazoles - administration & dosage (262) 262
valine - analogs & derivatives (261) 261
diuretics (258) 258
blood pressure monitoring, ambulatory (250) 250
internal medicine (249) 249
hydrochlorothiazide - therapeutic use (244) 244
cardiovascular events (239) 239
follow-up studies (232) 232
randomized controlled trials as topic (230) 230
health aspects (228) 228
hypertensive patients (224) 224
losartan (224) 224
atherosclerosis (221) 221
medicine, research & experimental (221) 221
adolescent (215) 215
amlodipine - pharmacokinetics (211) 211
atenolol (209) 209
clinical trials (209) 209
cardiology (208) 208
blood pressure - physiology (206) 206
cross-over studies (206) 206
pharmacology/toxicology (205) 205
calcium (204) 204
calcium channels (202) 202
methods (196) 196
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7349) 7349
Russian (223) 223
German (107) 107
Spanish (61) 61
French (56) 56
Japanese (48) 48
Chinese (39) 39
Polish (33) 33
Korean (31) 31
Portuguese (23) 23
Hungarian (21) 21
Italian (20) 20
Czech (15) 15
Ukrainian (10) 10
Croatian (9) 9
Swedish (6) 6
Danish (4) 4
Slovak (4) 4
Dutch (3) 3
Norwegian (3) 3
Turkish (3) 3
Bosnian (2) 2
Serbian (2) 2
Slovenian (2) 2
Hebrew (1) 1
Indonesian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Emergency Medicine, ISSN 0196-0644, 10/2016, Volume 68, Issue 4, p. S128-S129
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.annemergmed.2016.08.352 Byline: J.M. LeRoy, S.P. Boley, K.M.... 
Amlodipine
Journal Article
Journal of Clinical Periodontology, ISSN 0303-6979, 06/2018, Volume 45, Issue S19, pp. 378 - 378
Journal Article
Electrophoresis, ISSN 0173-0835, 08/2019, Volume 40, Issue 15, p. 1992
The enantioseparation of chiral drugs via CE was first investigated using [beta]-CD as chiral additive and deep eutectic solvents (DESs) as auxiliary additive.... 
Amlodipine | Investigations
Journal Article
Journal of Molecular and Cellular Cardiology, ISSN 0022-2828, 10/2008, Volume 45, Issue 4, p. S27
Journal Article
Journal of Clinical Periodontology, ISSN 0303-6979, 06/2018, Volume 45, Issue S19, pp. 441 - 441
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2010, Volume 32, Issue 7, pp. 1252 - 1269
Abstract Background: Patients with hypertension may require a combination of ≥2 antihypertensive agents to achieve blood pressure (BP) control. Objective: The... 
Internal Medicine | Medical Education | fixed-dose combination therapy | olmesartan medoxomil | blood pressure | antihypertensive therapy | amlodipine besylate | Antihypertensive therapy | Amlodipine besylate | Blood pressure | Olmesartan medoxomil | Fixed-dose combination therapy | METAANALYSIS | RESISTANT HYPERTENSION | CARDIOVASCULAR EVENTS | COMBINATION THERAPY | PREVENTION | CARDIAC OUTCOMES TRIAL | ADHERENCE | HIGH-BLOOD-PRESSURE | PHARMACOLOGY & PHARMACY | VALSARTAN | Follow-Up Studies | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Imidazoles - administration & dosage | Hypertension - drug therapy | Male | Tetrazoles - administration & dosage | Adult | Female | Blood Pressure - drug effects | Imidazoles - therapeutic use | Drug Therapy, Combination | Amlodipine - administration & dosage | Olmesartan Medoxomil | Hydrochlorothiazide - adverse effects | Severity of Illness Index | Double-Blind Method | Imidazoles - adverse effects | Amlodipine - adverse effects | Hydrochlorothiazide - administration & dosage | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Hydrochlorothiazide - therapeutic use | Drug Combinations | Hypertension | Medical research | Care and treatment | Diuretics | Amlodipine | Medicine, Experimental | Drug therapy, Combination | Index Medicus
Journal Article
Vascular Pharmacology, ISSN 1537-1891, 09/2006, Volume 45, Issue 3, pp. e69 - e69
Journal Article
BMC Cardiovascular Disorders, ISSN 1471-2261, 09/2016, Volume 16, Issue 1, pp. 168 - 168
Journal Article
Journal Article
Clinical Therapeutics, ISSN 0149-2918, 2012, Volume 34, Issue 3, pp. 537 - 551
Abstract Background Hypertensive patients with diabetes often require combination therapy to achieve a blood pressure (BP) goal, and evidence suggests that... 
Internal Medicine | Medical Education | metabolic syndrome | type 2 diabetes mellitus | single-pill combination | telmisartan/amlodipine | hypertension | obesity | Hypertension | Obesity | Single-pill combination | Telmisartan/amlodipine | Type 2 diabetes mellitus | Metabolic syndrome | UNITED-STATES | CARDIOVASCULAR EVENTS | PLUS AMLODIPINE | GUIDELINES | MICROVASCULAR OUTCOMES | CLINICAL EVENTS | UNCONTROLLED HYPERTENSION | HIGH-RISK PATIENTS | EUROPEAN COUNTRIES | PHARMACOLOGY & PHARMACY | AMBULATORY BLOOD-PRESSURE | Benzoates - adverse effects | Antihypertensive Agents - pharmacology | Benzoates - therapeutic use | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Benzimidazoles - administration & dosage | Female | Blood Pressure - drug effects | Benzimidazoles - adverse effects | Hypertension - diagnosis | Amlodipine - administration & dosage | Diabetes Mellitus, Type 2 - complications | Benzimidazoles - therapeutic use | Body Mass Index | Severity of Illness Index | Double-Blind Method | Amlodipine - adverse effects | Treatment Outcome | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Antihypertensive Agents - adverse effects | Benzoates - administration & dosage | Amlodipine - pharmacology | Benzoates - pharmacology | Hypertension - complications | Benzimidazoles - pharmacology | Aged | Diabetes Mellitus, Type 2 - drug therapy | Drug Combinations | Type 2 diabetes | Diabetics | Amlodipine | Clinical trials | Insulin resistance | Universities and colleges | Diabetes | Body mass index | Mortality | Drug therapy | Pharmaceutical industry | Drug dosages | Metabolic disorders | Index Medicus
Journal Article
03/2008
Background: Different factors are involved in the induction and progress of atherosclerosis. One of these factors is endothelin-1. Since, in atherosclerotic... 
atherosclerosis | Amlodipine | endothelin-1
Web Resource
Urology, ISSN 0090-4295, 07/2016, Volume 93, p. 224
To test the hypothesis that maxacalcitol, vitamin D.sub.3 analog, would ameliorate detrusor overactivity (DO) induced by retinyl acetate instillation; to test... 
Amlodipine | Oxybutynin | Vitamins
Journal Article
Journal Article